Loading provider…
Loading provider…
Dermatology Physician in Cleveland, OH
NPI: 1326067778Primary Practice Location
UH CLEVELAND MEDICAL CENTER
11100 Euclid Ave, Cleveland, OH
Primary Employer
University Hospitals Medical Group Inc
uhhospitals.org
HQ Phone
Get MD Neil's Phone Numberphone_androidMobile
Get MD Neil's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 148 | 213 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 75 | 102 |
| 3 | 17000Destruction of skin growth | 47 | 58 |
| 4 | 17003Destruction of 2-14 skin growths | 34 | 174 |
| 5 | 88350Antibody evaluation | 32 | 144 |
Diagnosis and management of pemphigus: Recommendations of an international panel of experts.
Authors: Annette Czernik, Sergei Grando, Christopher Hansen, Ron Feldman, Donna Culton, Julia Lehman, Adela Rambi Cardones, Luis Diaz, Victoria Werth, Matt Marinkovich, John Zone, David Fivenson, Emanual Maverakis, Sandra Pena, Aimee Payne
Publication Date: 2018-02-10
Authors: Mark Lebwohl, Joel Gelfand, Steven Feldman, Caitriona Ryan, Martin Menter, John Koo, Craig Elmets, Karl Beutner, Craig Leonardi
Journal: J Am Acad Dermatol
Publication Date: 2011-02-08
Lead Sponsor: Olix Pharmaceuticals, Inc.
Collaborators: Alira Health
Intervention / Treatment: DRUG: OLX10010
Lead Sponsor: University Hospitals Cleveland Medical Center
Intervention / Treatment: DRUG: Apremilast
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib